BCHE and Alzheimer disease: Work conducted in patients with AD has shown that cholinesterase inhibitors can affect resting-state EEG activity, where reductions in delta or theta activity have been observed after successful treatment, accompanied by increases in dominant alpha activity and cognitive functioning (Babiloni et al., 2013).